Vivos Therapeutics Inc./$VVOS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Ticker
$VVOS
Sector
Primary listing
Employees
270
Headquarters
Website
VVOS Metrics
BasicAdvanced
$7.1m
-
-$2.12
6.21
-
Price and volume
Market cap
$7.1m
Beta
6.21
52-week high
$7.95
52-week low
$0.49
Average daily volume
2.6m
Financial strength
Current ratio
0.269
Quick ratio
0.216
Long term debt to equity
-329.045
Total debt to equity
-968.272
Profitability
EBITDA (TTM)
-21.005
Gross margin (TTM)
61.79%
Net profit margin (TTM)
-127.70%
Operating margin (TTM)
-115.45%
Revenue per employee (TTM)
$70,000
Management effectiveness
Return on assets (TTM)
-77.74%
Return on equity (TTM)
-1,599.81%
Valuation
Price to revenue (TTM)
0.308
Price to book
-6.06
Price to tangible book (TTM)
-0.51
Price to free cash flow (TTM)
-0.306
Free cash flow yield (TTM)
-327.28%
Free cash flow per share (TTM)
-1.673
Growth
Revenue change (TTM)
33.77%
Earnings per share change (TTM)
24.39%
3-year revenue growth (CAGR)
6.42%
3-year earnings per share growth (CAGR)
-53.54%
VVOS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs